Enavate Sciences
ES
EN
Enavate Sciences
About
Key facts
At-a-glance profile data
- Portfolio companies
- 2
- Stages
- Series B
- Cheque size
- $200M to $200M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 9 Jan 2026 | AirNexis Therapeutics | Series A | $200M |
Add first review
Frequently asked
What companies has Enavate Sciences invested in?
Enavate Sciences has invested in AirNexis Therapeutics, Upstream Bio.
